Article
Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.
PloS one - 1 Jan 2015
Blancafort Adriana, Giró-Perafita Ariadna, Oliveras Glòria, Palomeras Sònia, Turrado Carlos, Campuzano Òscar, Carrión-Salip Dolors, Massaguer Anna, Brugada Ramon, Palafox Marta, Gómez-Miragaya Jorge, González-Suárez Eva, Puig Teresa
Abstract excerpt
Blocking the enzyme Fatty Acid Synthase (FASN) leads to apoptosis of HER2-positive breast carcinoma cells. The hypothesis is that blocking FASN, in combination with anti-HER2 signaling agents, would be an effective antitumor strategy in preclinical HER2+ breast cancer models of trastuzumab and lapatinib resistance. We developed and molecularly characterized in vitro HER2+ models of resistance to trastuzumab...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
